Pfizer and Moderna Raise Prices for COVID-19 Vaccines in EU: Financial Times

Pfizer and Moderna Raise Prices for COVID-19 Vaccines in EU: Financial Times
Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021. Dado Ruvic/Illustration/Reuters
Reuters
Updated:

Pfizer and Moderna have raised the prices of their COVID-19 vaccines in their latest European Union supply contracts, the Financial Times reported on Sunday.

The new price for the Pfizer shot was €19.50 ($23.15) against €15.50 ($18.40) previously, the newspaper said, citing portions of the contracts seen.